Press release
Autologous Stem Cell and Non-Stem Cell Based Therapies Market is projected to reach USD 18.4 billion by 2031 | Major Companies - MEDIPOST, Novartis AG, Gilead Sciences Inc.
Autologous Stem Cell and Non-Stem Cell Based Therapies Market
The Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market size reached USD 6.8 billion in 2022 and is projected to reach USD 18.4 billion by 2031, growing at a CAGR of 13.7% during the forecast period 2024 to 2031.
The Autologous Stem Cell and Non-Stem Cell Based Therapies Market encompasses the development, manufacturing, and commercialization of treatments derived from a patient's own cells. It includes regenerative therapies using stem cells or other autologous cells to treat chronic diseases, injuries, and degenerative conditions. The market focuses on personalized, safe, and innovative therapies with growing clinical applications worldwide.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/autologous-stem-cell-and-non-stem-cell-based-therapies-market?sz
(Single User Report: USD 3480 & One Year Database Subscription: USD 10K)
Recent Key Developments of United States:
✅ December 2025: U.S. researchers launched a large-scale clinical trial for autologous non-stem cell therapies targeting neurodegenerative diseases like Parkinson's.
✅ November 2025: A major U.S. biotech firm announced Phase III trial results showing improved survival rates with autologous stem cell therapy for heart failure.
✅ October 2025: The FDA granted accelerated approval to a novel autologous CAR-T cell therapy for relapsed multiple myeloma, enhancing treatment options for blood cancer patients.
Recent Key Developments of Japan:
✅ December 2025: Metcela Inc. reported positive interim data from its autologous cardiac stem cell therapy trials, advancing toward commercialization.
✅ November 2025: Biostar Stem Cell Research Institute expanded its autologous fat-derived stem cell therapy for Alzheimer's to more clinics in Japan.
✅ October 2025: Japan's PMDA approved an autologous stem cell treatment for osteoarthritis, supported by the Sakigake fast-track system for regenerative medicine.
List of the Key Players in the Autologous Stem Cell and Non-Stem Cell Based Therapies Market:
MEDIPOST
Novartis AG
BrainStorm Cell Limited
Caladrius
Cytori Therapeutics Inc.
Gilead Sciences Inc.
Regeneus Ltd
U.S. Stem Cell, Inc
Vericel Corporation
Castle Creek Biosciences, Inc.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/autologous-stem-cell-and-non-stem-cell-based-therapies-market?sz
(Single User Report: USD 3480 & One Year Database Subscription: USD 10K)
This Report Covers:
✔ Go-to-market Strategy.
✔ Neutral perspective on the market performance.
✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
✔Customized regional/country reports as per request and country level analysis.
✔ Potential & niche segments and regions exhibiting promising growth covered.
✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Segments Covered in the Autologous Stem Cell and Non-Stem Cell Based Therapies Market:
By Type: Autologous Stem Cells, Autologous Non-Stem cells, Others.
By Application: Cancer, Neurodegenerative Disorders, Cardiovascular Disease, Orthopedic Diseases, Others.
By End-User: Hospitals, Ambulatory Surgical Centers, Research Facilities, Other.
Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=autologous-stem-cell-and-non-stem-cell-based-therapies-market
Chapter Outline
⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Autologous Stem Cell and Non-Stem Cell Based Therapies market segments, study objectives, and years considered.
⏩ Market Landscape: The competition in the Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.
⏩ Companies Profiles: The Global Autologous Stem Cell and Non-Stem Cell Based Therapies market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.
⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.
⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Autologous Stem Cell and Non-Stem Cell Based Therapies Market.
⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.
⏩ Research Findings: This section of the report showcases the findings and analysis of the report.
⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
People Also Ask:
◆ How big is the Autologous Stem Cell and Non-Stem Cell Based Therapies Market in 2025?
◆ What is the projected growth rate of the Autologous Stem Cell and Non-Stem Cell Based Therapies Market through 2033?
◆ Who are the key players in the Autologous Stem Cell and Non-Stem Cell Based Therapies Market?
◆ Which region is expected to dominate the industry during the forecast period?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Autologous Stem Cell and Non-Stem Cell Based Therapies Market is projected to reach USD 18.4 billion by 2031 | Major Companies - MEDIPOST, Novartis AG, Gilead Sciences Inc. here
News-ID: 4366020 • Views: …
More Releases from DataM Intelligence 4Market Research
Solar Energy Market Set to Surge as Global Demand for Clean Power Reaches Record …
Market Overview:
The Solar Energy Market is estimated to grow at a CAGR of 5.9% during the forecast period 2024-2031.
The Solar Energy Market refers to the global industry involved in the development, manufacturing, installation, and operation of technologies that convert sunlight into electricity and heat. It includes photovoltaic panels, solar thermal systems, inverters, energy storage, and related services, driven by rising renewable energy adoption, sustainability goals, and government incentives worldwide.
Get a…
Breast Cancer Treatment Market is expected to reach US$ 72.05 billion by 2033 | …
Market Size and Growth:
The Breast Cancer Treatment Market size reached US$ 37.75 billion in 2024 and is expected to reach US$ 72.05 billion by 2033, growing at a CAGR of 9.4% during the forecast period 2025-2033.
The Breast Cancer Treatment Market encompasses pharmaceuticals, biologics, targeted therapies, immunotherapies, hormonal treatments, radiation, and surgical solutions used to diagnose, manage, and cure breast cancer. It includes innovations in precision medicine, supportive care, and healthcare…
Machine Vision Logistics Market Set to Soar with Smarter, Faster Supply Chains 2 …
Market Overview:
The Global Machine Vision Logistics Market is expected to reach at a CAGR of 7.8% during the forecast period (2024-2031).
The Machine Vision Logistics Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative…
Green Building Materials Market Set to Soar: Innovations, Growth Trends, and Sus …
Market Overview:
The Global Green Building Materials Market is expected to grow at a CAGR 12.1% during the forecasting period (2024-2031).
The Green Building Materials Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research…
More Releases for Stem
Animal Stem Cell Therapy Market Worth Observing Growth| Cell Therapy Sciences, M …
Advance Market Analytics published a new research publication on "Animal Stem Cell Therapy Market Insights, to 2030" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Animal Stem Cell Therapy market was mainly driven by the increasing R&D spending across the world. Some of…
Introducing My STEM Resume: The Ultimate Solution for STEM Professionals
As STEM industries continue to grow, so does the demand for qualified professionals. Yet, many STEM students and professionals face challenges in effectively showcasing their skills and experience to prospective employers. Recognizing this need, Brendon, a seasoned STEM professional, has developed a groundbreaking solution: My STEM Resume.
My STEM Resume is a cutting-edge app designed specifically for STEM professionals, offering a comprehensive suite of tools to streamline the resume creation and…
Animal Stem Cell Therapy Market 2022: Allogeneic Stem Cells Popular Sourcing Cho …
The global animal stem cell therapy market recorded sales of around US$ 249.9 Mn in 2021 and the market is predicted to experience healthy growth over the years ahead at a CAGR of 5.2% (2022 to 2032).
Request For Free Sample Report of "Animal Stem Cell Therapy Market"@ https://www.persistencemarketresearch.com/samples/14941
Animal stem cell therapies are treatments for disorders such as arthritis, soft tissue injuries, traumatic fractures, tendonitis, inflammatory bowel disease, and others that…
Animal Stem Cell Therapy Market 2021 Research Report by Experts- Magellan Stem C …
Global Animal Stem Cell Therapy Market Size, Status and Forecast 2022
The Global Animal Stem Cell Therapy Market Research Report 2022-2027 is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive…
Stem Cells Market: Development of Infrastructure to Drive Global Stem Cells Mark …
In the global stem cells market a sizeable proportion of companies are trying to garner investments from organizations based overseas. This is one of the strategies leveraged by them to grow their market share. Further, they are also forging partnerships with pharmaceutical organizations to up revenues.
Read Report Overview - https://www.transparencymarketresearch.com/stem-cells-market.html
In addition, companies in the global stem cells market are pouring money into expansion through multidisciplinary and multi-sector collaboration for large…
Global Animal Stem Cell Therapy Market Detailed Analysis 2018-2025 : MediVet Bio …
Qyresearchreports include new market research report “Global Animal Stem Cell Therapy Market Research Report 2018” to its huge collection of research reports.
Animal stem cell therapy is a usage of animals stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process…
